Top Biotech and Pharma M&A of Q1 2015
2015 has been an exciting year for the biotech and pharmaceutical industries, with major M&A activity...
August 10th, 2015
2015 has been an exciting year for the biotech and pharmaceutical industries, with major M&A activity...
Aimmune Therapeutics exceeded expectations with an $160-million IPO on Thursday.
NantKwest hit the stock market on Tuesday with an initial public offering hat values the company...
Biogen's share price dropped 19 percent on Friday, but some market watchers believe that's a buying...
Last year was a stellar year for biotech investment, with the Amex Biotechnology Index growing an...
The EY Biotechnology Industry Report 2014 identifies Gilead Sciences, Amgen, Celgene and Biogen Idec as the...
biOasis Technologies released interesting news on Monday, but understanding what it means requires a little bit...